Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)

China flag China · Delayed Price · Currency is CNY
48.78
+0.79 (1.65%)
At close: Aug 4, 2026
Market Cap1.89B -8.4%
Revenue (ttm)163.34M -5.7%
Net Income13.86M
EPS0.36
Shares Out 38.78M
PE Ratio137.35
Forward PEn/a
Dividend1.15 (2.40%)
Ex-Dividend DateJun 10, 2026
Volume450,787
Open48.26
Previous Close47.99
Day's Range47.07 - 49.28
52-Week Range40.00 - 63.56
Beta0.30
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About SHA:688193

Shanghai Rendu Biotechnology Co., Ltd. engages in the research, development, production, and sales of molecular diagnostic reagents products and supporting equipment in China and internationally. Its products are used in various therapeutic areas, including reproductive tract, respiratory tract, enterovirus infections, and bloodborne infectious diseases, as well as tumor auxiliary diagnosis. The company was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 239
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688193
Full Company Profile

Financial Performance

Financial Statements